 |
|
Topical Fibronectin and Aprotinin for Keratectomy Wound Healing in Rabbits
Hélène M. Boisjoly, MD;
Ran Sun, MD, MSc;
Marcelle Giasson;
André Beaulieu, MD
Arch Ophthalmol. 1990;108(12):1758-1763.
Abstract
• We evaluated the effect of fibronectin (an adhesive protein) and aprotinin (a protease inhibitor) as single or combined topical therapies for primary healing and prevention of recurrent corneal epithelial defects in the rabbit keratectomy wound model. The biological activity of the prepared solutions of rabbit plasma fibronectin (0.6 g/L) was suggested by in vitro assays of rabbit corneal epithelial cell adhesion and gelatin-binding affinity. In the first experiment, we compared fibronectin, albumin (a control nonadhesive protein), and saline. In the second and third experiments, fibronectin supplemented with aprotinin, aprotinin alone, and saline were compared; aprotinin was used at concentrations of 40 and 1000 kallikrein inactivating units (KIU) per milliliter. Our results suggest that topical fibronectin, 0.6 g/L, as well as aprotinin at 40- and 1000-KIU/mL concentrations, given alone or in combination, neither promote corneal epithelial wound healing nor prevent recurrent corneal epithelial defects in rabbit keratectomy wounds.
Author Affiliations
From the Ophthalmology (Drs Boisjoly and Sun and Mr Giasson) and Inflammation-Immunology-Rheumatology (Dr Beaulieu) Research Units, Centre Hospitalier Université Laval Research Center, Laval University, Ste-Foy, Québec.
Footnotes
Accepted for publication June 12, 1990.
Reprint requests to Room S-5, Centre Hospitalier Université Laval Research Center, 2705 Laurier, Ste-Foy, Québec, Canada G1V 4G2 (Dr Boisjoly).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
